Cargando…

TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluorescent staining

Triple‐negative breast cancer (TNBC) is a highly aggressive tumour that lacks marker for targeted diagnosis. Recently, it was reported that toll‐like receptor 5 (TLR5) was associated with some kind of tumours, especially in TNBC, but whether it could be used as a non‐invasive monitoring target is no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Dai, Liu, Weiwei, Zhao, Shanshan, Zhang, Chao, Liang, Ting, Hou, Guihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850942/ https://www.ncbi.nlm.nih.gov/pubmed/31576678 http://dx.doi.org/10.1111/jcmm.14707

Ejemplares similares

TLR5: A prognostic and monitoring indicator for triple-negative breast cancer
por: Shi, Dai, et al.
Publicado: (2019)

Radioimmunoimaging of (125)I-labeled anti-CD93 monoclonal antibodies in a xenograft model of non-small cell lung cancer
por: Liu, Weiwei, et al.
Publicado: (2019)

Down-Regulation of Toll-Like Receptor 5 (TLR5) Increased VEGFR Expression in Triple Negative Breast Cancer (TNBC) Based on Radionuclide Imaging
por: Jiang, Wen, et al.
Publicado: (2021)

HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
por: Altunay, Betül, et al.
Publicado: (2020)

Radioimmunoimaging of Liver Metastases with PET Using a (64)Cu-Labeled CEA Antibody in Transgenic Mice
por: Nittka, Stefanie, et al.
Publicado: (2014)

A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging
por: Yamamura, Miyuki, et al.
Publicado: (1996)

Evaluation of novel highly specific antibodies to cancer testis antigen Centrin‐1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer
por: Jiao, Rubin, et al.
Publicado: (2019)

Fibroblast growth factor receptor 4 as a prognostic indicator in triple-negative breast cancer
por: Wei, Wei, et al.
Publicado: (2020)

Click-to-Release: Cleavable Radioimmunoimaging with [(89)Zr]Zr-DFO-Trans-Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio
por: Vlastara, Maria, et al.
Publicado: (2023)

Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma
por: Broqueza, Jaline, et al.
Publicado: (2021)

EGFR expression is associated with cytoplasmic staining of CXCR4 and predicts poor prognosis in triple-negative breast carcinomas
por: Li, Rong-Hui, et al.
Publicado: (2017)

Bonney's Rapid Triple Stain
Publicado: (1908)

Pretargeted radioimmunoimaging with a biotinylated D-D(3) construct and (99m)Tc-DTPA-biotin: strategies for early diagnosis of small cell lung cancer
por: Hong, Zhihui, et al.
Publicado: (2020)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Nanomaterial Technology and Triple Negative Breast Cancer
por: Hou, Kai, et al.
Publicado: (2022)

Quantitative stain-free imaging and digital profiling of collagen structure reveal diverse survival of triple negative breast cancer patients
por: Gole, Laurent, et al.
Publicado: (2020)

The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
por: Giacomini, Arianna, et al.
Publicado: (2023)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Gold Nanobipyramids for Near-Infrared Fluorescence-Enhanced Imaging and Treatment of Triple-Negative Breast Cancer
por: Theodorou, Ioannis G., et al.
Publicado: (2023)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

T-bet(+) lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2019)

Non-invasive imaging of allogeneic transplanted skin graft by (131)I-anti-TLR5 mAb
por: Sun, Hukui, et al.
Publicado: (2014)

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
por: Jiang, Tingting, et al.
Publicado: (2016)

IL‐27 Rα(+) cells promoted allorejection via enhancing STAT1/3/5 phosphorylation
por: Zhao, Shanshan, et al.
Publicado: (2020)

IL-27Rα: A Novel Molecular Imaging Marker for Allograft Rejection
por: Zhao, Shanshan, et al.
Publicado: (2020)

Azurocidin 1 inhibits the aberrant proliferation of triple‑negative breast cancer through the regulation of pyroptosis
por: Lei, Shanshan, et al.
Publicado: (2023)

High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma
por: Shi, Chun-Tao, et al.
Publicado: (2019)

Adhesion of Triple-Negative Breast Cancer Cells under Fluorescent and Soft X-ray Contact Microscopy
por: Osuchowska, Paulina Natalia, et al.
Publicado: (2021)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Huang, Yunxia, et al.
Publicado: (2023)

Triple-negative breast cancer: is there a treatment on the horizon?
por: Yao, Hui, et al.
Publicado: (2016)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

Roles of eIF3m in the tumorigenesis of triple negative breast cancer
por: Han, Wei, et al.
Publicado: (2020)

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Triple Negative Breast Cancer – An Overview
por: Aysola, Kartik, et al.
Publicado: (2013)

Male Triple-Negative Breast Cancer
por: Qavi, Qasif, et al.
Publicado: (2021)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Theranostics for Triple-Negative Breast Cancer
por: Choi, Hyeryeon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n4bh8i4e0jgl6tssjdcoem2j53